Evaluation of expression profiles of microRNAs and two target genes, FOXO3a and RUNX2, effectively supports diagnostics and therapy predictions in breast cancer / D. Jurkovicova ... [et al.]. Neoplasma Vol. 63, no. 6 (2016), s. 941-951